AXIM BIOTECHNOLOGIES, INC. Increase (Decrease) in Accrued Interest Receivable, Net
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Increase (Decrease) in Accrued Interest Receivable, Net of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2023-05-22
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2022-03-31 was $256.00.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accrued interest receivable, net for fiscal 2022 was -$1.70K, a 265.79% decline from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accrued interest receivable, net for fiscal 2021 was $1.03K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accrued interest receivable, net for fiscal 2020 was -$675.00.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month as first filed |
|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-22 | ||
| 2022-12-31 | -$1.70K 10-K · filed 2023-04-17 | ||
| 2022-03-31 | $256.00 10-Q · filed 2023-05-22 | ||
| 2021-12-31 | $1.03K 10-K · filed 2023-04-17 | -$1.03K 10-K/A · filed 2022-04-19 | |
| 2020-12-31 | -$675.00 10-K/A · filed 2022-04-19 |